China Literature Limited (China Literature) disclosed that it repurchased 400,000 ordinary shares on 2 July 2026 via on-market transactions at prices between HK$19.27 and HK$20.00 per share, for a total consideration of HK$7.82 million.

Including this latest tranche, the company has bought back 8.80 million shares since the current mandate was approved on 2 June 2026, representing 0.86% of the 1.02 billion shares in issue on the mandate date. All repurchased shares are designated for cancellation and remain outstanding pending formal cancellation.

Balance-sheet impact remains limited: the company’s issued share capital stood unchanged at 1.02 billion shares as of the close on 2 July 2026, as cancellations had not yet been processed.

China Literature is authorised to repurchase up to 102.15 million shares under the existing mandate, leaving more than 93 million shares of headroom. In line with Hong Kong listing rules, the company is subject to a moratorium on new share issues or treasury-share sales until 1 August 2026.